Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Doxycycline
Dopharma Research B.V.
QJ01AA02
Doxycycline
Powder for use in drinking water
POM-V - Prescription Only Medicine – Veterinarian
Chickens, Turkeys
Antimicrobial
Authorized
2015-05-29
Revised: June 2020 AN: 01069/2019 PAGE 1 OF 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Doxylin, 433 mg/g, powder for use in drinking water for chickens and turkeys 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One gram contains: _ACTIVE SUBSTANCE:_ Doxycycline: 433.3 mg (as doxycycline hyclate 500.0 mg) _EXCIPIENTS_: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Powder for use in drinking water. Yellow, crystalline powder. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (broilers, broiler breeders) and turkeys (broilers, breeders). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Treatment of clinical respiratory infections associated with _Mycoplasma _ _gallisepticum_ susceptible to doxycycline. 4.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use when tetracycline resistance has been detected in the herd/flock due to the potential for cross resistance. Do not use in animals with hepatic dysfunction. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The uptake of medication by animals can be altered as a consequence of illness. In case of insufficient uptake of drinking water, animals should be treated parenterally. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Due to variability (time, geographical) in susceptibility of bacteria for doxycycline, bacteriological sampling and susceptibility testing of micro-organisms from diseased animals on farm are highly recommended. Revised: June 2020 AN: 01069/2019 PAGE 2 OF 6 Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to doxycycline and may decrease effectiveness of treatment with tetracyclines due to the potential for cross resistance. Use of the product should take into account official and local antimicrobial policies. Avoid administration in oxidized drinking equipment. As eradication of the target pathogens may not be achieved, medi Read the complete document